- Info
- Significant Ownership
Significant Ownership of Growth Equity Opportunities 18 VGE, LLC
- Signature - Title
- /s/ Zachary Bambach - Zachary Bambach as attorney-in-fact for Anthony A. Florence Jr., Managing Partner and Co-Chief Executive Officer
- Location
- Timonium, MD
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Growth Equity Opportunities 18 VGE, LLC.
Follow Filing Activity
Follow Growth Equity Opportunities 18 VGE, LLC and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of Growth Equity Opportunities 18 VGE, LLC
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| XFOR | X4 Pharmaceuticals, Inc. | Common Stock, par value $0.001 per share | 6.2% | $17,496,802 | +$9,734,867 | 5,057,610 | +125% | Growth Equity Opportunities 18 VGE, LLC | 27 Oct 2025 |
| CELC | Celcuity Inc. | Common Stock, $0.001 par value per share | 4.9% | $238,224,023 | -$65,143,750 | 2,285,561 | -21% | Growth Equity Opportunities 18 VGE, LLC | 05 Mar 2026 |
| GOSS | Gossamer Bio, Inc. | Common Stock, $0.0001 par value per share | 1.7% | $10,366,092 | 4,065,134 | Growth Equity Opportunities 18 VGE, LLC | 23 Feb 2026 |
Schedules 13D/G Reported by Growth Equity Opportunities 18 VGE, LLC:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.